🐦 推特OkloQwen · 实盘不做把握 2/10不做原因:无增量信息
北京时间·🕒 发布 22:29:41时区推断·⟳ 抓取 22:30:13·⚡ 决策 09-04 22:32:01 +1m48s·53.0 天前
Oklo发推回顾Groves反应堆临界里程碑并重申2027年初同位素商业收入目标
该推文是Oklo官方账号的回顾性企业叙事帖，核心内容（Groves临界）为已公开旧事，唯一前瞻信息（2027年初同位素商业收入）在2026年5月券商研报中已有覆盖，不构成新增催化。股价无反应，无交易edge。
📄 原文Oklo@oklo↗ 原文
Reaching criticality at Groves was a major milestone. It was also just the beginning. In less than a year, Oklo built o…
不做 Oklo Inc（OKLO.US）
公司自有Twitter的回顾性IR帖子，核心内容（Groves临界）为已公开旧事，前瞻目标（2027同位素收入）已被券商覆盖，无新增可交易事实；股价无反应，无edge
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Oklo于2026-09-04在Twitter发布回顾性帖子，总结Groves反应堆临界里程碑（过去时态）并重申2027年初同位素商业收入目标。经核查：1）临界事件为此前已公开的旧闻；2）同位素业务时间线在2026年5月券商研报中已被覆盖（'Reinstate Buy'报告明确提及同位素业务为第三增长支柱）；3）股价当日仅+0.25%，市场无任何反应。该帖子本质是企业IR/营销内容，不含新增可交易事实。
🔎 新鲜度:最早出现 2026-09-04 · 扩散 low · price-in 风险 low ↗
先例如何影响了这次决策
对本次决策的影响:无需先例——事件本身不含新增可交易事实，不构成催化
工具执行结果 · 成功 4 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 1,111 ms
{"result": "search_processed_events:agent query=`oklo groves reactor criticality | oklo idaho radioisotope laboratory commercial | oklo isotope revenue 2027`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 72.0/72 小时、7287 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agent query 表达式没有召回候选，不能据此证明消息首发或不是重复；按当前事件继续正常研判。"} - kb_search 成功 stock_tools HTTP · 3,642 ms
{ - stock_quote 成功 stock_tools HTTP · 3,249 ms
{ - kb_fetch_document 成功 stock_tools HTTP · 1,812 ms
{
原文全文
展开原文 · 917 字
Reaching criticality at Groves was a major milestone. It was also just the beginning.
In less than a year, Oklo built our Groves Isotope Test Reactor from the ground up and brought it to criticality, demonstrating our ability to move from design to operation on a timeline few thought possible.
What we learned extends far beyond Groves. The project gave our team hands-on experience across engineering, construction, regulatory execution, startup, and operations that we can apply as we advance projects across power, fuel, and isotopes.
Now, we're putting that experience to work as we build toward commercial scale. That includes targeting our first commercial isotope revenue in early 2027 through our NRC-licensed Idaho Radioisotope Laboratory, while advancing our power and fuel projects toward deployment.
Groves demonstrated our ability to build, learn, and repeat. Now, we're doing it across the business.
In less than a year, Oklo built our Groves Isotope Test Reactor from the ground up and brought it to criticality, demonstrating our ability to move from design to operation on a timeline few thought possible.
What we learned extends far beyond Groves. The project gave our team hands-on experience across engineering, construction, regulatory execution, startup, and operations that we can apply as we advance projects across power, fuel, and isotopes.
Now, we're putting that experience to work as we build toward commercial scale. That includes targeting our first commercial isotope revenue in early 2027 through our NRC-licensed Idaho Radioisotope Laboratory, while advancing our power and fuel projects toward deployment.
Groves demonstrated our ability to build, learn, and repeat. Now, we're doing it across the business.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。